Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin versus placebo in pulmonary arterial hypertension
ISRCTN63558875Phase 3Terminated
- Sponsor
- Heidelberg University Hospital
- Start
- Apr 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in pulmonary arterial hypertension (PAH) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Six-minute walk test. Started Apr 2007; status: terminated.
02
Drugs
atorvastatin
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on ISRCTN63558875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63558875.